Travere Therapeutics Inc (NAS:TVTX)
$ 6.16 -0.18 (-2.84%) Market Cap: 468.95 Mil Enterprise Value: 431.93 Mil PE Ratio: 0 PB Ratio: 6.33 GF Score: 54/100

Q3 2021 Travere Therapeutics Inc Earnings Call Transcript

Oct 28, 2021 / 08:30PM GMT
Release Date Price: $26.59 (+1.49%)
Operator

Good day, and thank you for standing by, and welcome to Travere Therapeutics Third Quarter 2021 Financial Results and Corporate Update Call. (Operator Instructions) Please be advised that this call is being recorded. (Operator Instructions)

I would now like to hand the conference over to Chris Cline, Senior Vice President, Investor Relations, Corporate Communications. Please go ahead.

Chris Cline
Travere Therapeutics, Inc. - SVP of IR & Corporate Communications

Thank you, Justin. Good afternoon, and welcome to Travere Therapeutics' Third Quarter 2021 Financial Results and Corporate Update Call. Thank you all for joining us. Today's call will be led by our Chief Executive Officer, Dr. Eric Dube. Eric will be joined for the prepared remarks by Dr. Noah Rosenberg, our Chief Medical Officer; Peter Heerma, our Chief Commercial Officer; and our Chief Financial Officer, Laura Clague. Dr. Bill Rote, Senior Vice President of Research and Development, will join us for the Q&A session.

Before we begin, I would like to remind everyone that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot